234 related articles for article (PubMed ID: 37563616)
21. Oocyte cryopreservation review: outcomes of medical oocyte cryopreservation and planned oocyte cryopreservation.
Walker Z; Lanes A; Ginsburg E
Reprod Biol Endocrinol; 2022 Jan; 20(1):10. PubMed ID: 34996479
[TBL] [Abstract][Full Text] [Related]
22. DuoStim protocol- a novel fertility preservation strategy for female oncology patients.
Puthur SJ; Tracey S; Gould D; Fitzgerald CT
Hum Fertil (Camb); 2023 Dec; 26(5):1361-1367. PubMed ID: 36999567
[TBL] [Abstract][Full Text] [Related]
23. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
Toftager M; Bogstad J; Løssl K; Prætorius L; Zedeler A; Bryndorf T; Nilas L; Pinborg A
Hum Reprod; 2017 Mar; 32(3):556-567. PubMed ID: 28130435
[TBL] [Abstract][Full Text] [Related]
24. Usefulness of random-start progestin-primed ovarian stimulation for fertility preservation.
Huang H; Itaya Y; Samejima K; Ichinose S; Narita T; Matsunaga S; Saitoh M; Takai Y
J Ovarian Res; 2022 Jan; 15(1):2. PubMed ID: 34983605
[TBL] [Abstract][Full Text] [Related]
25. Ovarian tissue cryopreservation can be combined simultaneously with oocyte retrieval after controlled ovarian hyperstimulation.
Puy V; Dupeux M; Mayeur A; Grynberg M; Benoit A; Bendayan M; Zhegari F; Hesters L; Gallot V; Prevot S; Frydman N; Sonigo C
Hum Reprod; 2023 May; 38(5):860-871. PubMed ID: 36860186
[TBL] [Abstract][Full Text] [Related]
26. A prospective study of women and girls undergoing fertility preservation due to oncologic and non-oncologic indications in Sweden-Trends in patients' choices and benefit of the chosen methods after long-term follow up.
Rodriguez-Wallberg KA; Marklund A; Lundberg F; Wikander I; Milenkovic M; Anastacio A; Sergouniotis F; Wånggren K; Ekengren J; Lind T; Borgström B
Acta Obstet Gynecol Scand; 2019 May; 98(5):604-615. PubMed ID: 30723910
[TBL] [Abstract][Full Text] [Related]
27. Live births following fertility preservation using in-vitro maturation of ovarian tissue oocytes.
Segers I; Bardhi E; Mateizel I; Van Moer E; Schots R; Verheyen G; Tournaye H; De Vos M
Hum Reprod; 2020 Sep; 35(9):2026-2036. PubMed ID: 32829388
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of fertility preservation in women with endometriosis: comparison of progestin-primed ovarian stimulation versus antagonist protocols.
Mathieu d'Argent E; Ferrier C; Zacharopoulou C; Ahdad-Yata N; Boudy AS; Cantalloube A; Levy R; Antoine JM; Daraï E; Bendifallah S
J Ovarian Res; 2020 Feb; 13(1):18. PubMed ID: 32054493
[TBL] [Abstract][Full Text] [Related]
29. Successful Oocyte Cryopreservation in Reproductive-Aged Cancer Survivors.
Druckenmiller S; Goldman KN; Labella PA; Fino ME; Bazzocchi A; Noyes N
Obstet Gynecol; 2016 Mar; 127(3):474-480. PubMed ID: 26855092
[TBL] [Abstract][Full Text] [Related]
30. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.
Abir R; Ben-Aharon I; Garor R; Yaniv I; Ash S; Stemmer SM; Ben-Haroush A; Freud E; Kravarusic D; Sapir O; Fisch B
Hum Reprod; 2016 Apr; 31(4):750-62. PubMed ID: 26848188
[TBL] [Abstract][Full Text] [Related]
31. Ovarian reserve and response to stimulation in women undergoing fertility preservation according to malignancy type.
Lefebvre T; Mirallié S; Leperlier F; Reignier A; Barrière P; Fréour T
Reprod Biomed Online; 2018 Aug; 37(2):201-207. PubMed ID: 29784618
[TBL] [Abstract][Full Text] [Related]
32. Thirteen years' experience in fertility preservation for cancer patients after in vitro fertilization and in vitro maturation treatments.
Creux H; Monnier P; Son WY; Buckett W
J Assist Reprod Genet; 2018 Apr; 35(4):583-592. PubMed ID: 29502188
[TBL] [Abstract][Full Text] [Related]
33. Oocyte cryopreservation for fertility preservation in women with ovarian endometriosis.
Kim SJ; Kim SK; Lee JR; Suh CS; Kim SH
Reprod Biomed Online; 2020 Jun; 40(6):827-834. PubMed ID: 32295746
[TBL] [Abstract][Full Text] [Related]
34. Fertility preservation treatment for young women with autoimmune diseases facing treatment with gonadotoxic agents.
Elizur SE; Chian RC; Pineau CA; Son WY; Holzer HE; Huang JY; Gidoni Y; Levin D; Demirtas E; Tan SL
Rheumatology (Oxford); 2008 Oct; 47(10):1506-9. PubMed ID: 18660508
[TBL] [Abstract][Full Text] [Related]
35. The number of oocytes associated with maximum cumulative live birth rates per aspiration depends on female age: a population study of 221 221 treatment cycles.
Law YJ; Zhang N; Venetis CA; Chambers GM; Harris K
Hum Reprod; 2019 Sep; 34(9):1778-1787. PubMed ID: 31398253
[TBL] [Abstract][Full Text] [Related]
36. Progestin-Primed Ovarian Stimulation Versus Mild Stimulation Protocol in Advanced Age Women With Diminished Ovarian Reserve Undergoing Their First
Tu X; You B; Jing M; Lin C; Zhang R
Front Endocrinol (Lausanne); 2021; 12():801026. PubMed ID: 35140685
[TBL] [Abstract][Full Text] [Related]
37. Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study.
Diaz-Garcia C; Domingo J; Garcia-Velasco JA; Herraiz S; Mirabet V; Iniesta I; Cobo A; Remohí J; Pellicer A
Fertil Steril; 2018 Mar; 109(3):478-485.e2. PubMed ID: 29428307
[TBL] [Abstract][Full Text] [Related]
38. Live birth rate after female fertility preservation for cancer or haematopoietic stem cell transplantation: a systematic review and meta-analysis of the three main techniques; embryo, oocyte and ovarian tissue cryopreservation.
Fraison E; Huberlant S; Labrune E; Cavalieri M; Montagut M; Brugnon F; Courbiere B
Hum Reprod; 2023 Mar; 38(3):489-502. PubMed ID: 36421038
[TBL] [Abstract][Full Text] [Related]
39. In vitro maturation of oocytes for preserving fertility in autoimmune premature ovarian insufficiency.
Grynberg M; Jacquesson L; Sifer C
Fertil Steril; 2020 Oct; 114(4):848-853. PubMed ID: 32709383
[TBL] [Abstract][Full Text] [Related]
40. Ovarian stimulation for fertility preservation in women with cancer: A systematic review and meta-analysis comparing random and conventional starts.
Alexander VM; Martin CE; Schelble AP; Laufer AB; Hardi A; McKenzie LJ; Hipp HS; Kawwass JF; Spencer JB; Jungheim ES
J Gynecol Obstet Hum Reprod; 2021 Oct; 50(8):102080. PubMed ID: 33545413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]